These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25597478)

  • 1. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese.
    Yiu MK; Li CM; Hou SM; Wong CW; Tam S; Chu SK
    Hong Kong Med J; 2013 Dec; 19(6):504-10. PubMed ID: 23787257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
    Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
    Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
    Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
    Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study.
    Hung MJ; Chou CL; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2013 May; 112(5):276-82. PubMed ID: 23660224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.
    Jung HB; Choi DK; Lee SH; Cho ST; Na HR; Park MH
    Int Braz J Urol; 2017; 43(2):256-263. PubMed ID: 27802001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of Thai-Version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the Correlations of OABSS with Voiding Diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) Questionnaires.
    Bunyavejchevin S
    J Med Assoc Thai; 2015 Nov; 98(11):1064-74. PubMed ID: 26817176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urge perception index of bladder hypersensitivity.
    Fujihara A; Ukimura O; Honjo H; Iwata T; Ueda T; Matsugasumi T; Kamoi K; Okihara K; Kawauchi A; Miki T
    J Urol; 2013 May; 189(5):1797-803. PubMed ID: 23201494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.
    Homma Y; Yoshida M; Seki N; Yokoyama O; Kakizaki H; Gotoh M; Yamanishi T; Yamaguchi O; Takeda M; Nishizawa O
    Urology; 2006 Aug; 68(2):318-23. PubMed ID: 16904444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
    Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools.
    Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA
    Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome.
    Song M; Chun JY; Yoo DS; Han JY; Choo MS
    Low Urin Tract Symptoms; 2014 Sep; 6(3):180-4. PubMed ID: 26663602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness and minimal clinically important change in overactive bladder symptom score.
    Gotoh M; Homma Y; Yokoyama O; Nishizawa O
    Urology; 2011 Oct; 78(4):768-73. PubMed ID: 21855969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.
    Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V
    Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.